Tag: Diabetes: Type II
AHA: Intensive Strategy for Lowering Systolic BP Beneficial in Type 2 Diabetes
Significantly lower incidence of major cardiovascular events seen with intensive- versus standard-treatment strategy
Metformin Use Tied to Lower Rate of Asthma Attacks
Further reductions seen with the use of glucagon-like peptide-1 receptor agonists
Risk for Mortality Up With Low Income in Type 2 Diabetes
More prominent increase in mortality risk seen for younger adults aged 20 to 39 years
ASH: GLP-1 RA Use Tied to Lower Rate of Venous Thromboembolism in Diabetes
Significant reduction seen in VTE rates, with similar reductions for patients with and without obesity
Semaglutide Linked to Reduced Risk for Alzheimer Diagnosis in T2DM
Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
Rosuvastatin tied to cardiovascular and mortality benefits but also higher risk for type 2 diabetes
Eucaloric Carbohydrate-Restricted Diet Improves β-Cell Function in T2DM
Significant effect on acute and maximal C-peptide response at 12 weeks seen with carbohydrate-restricted diet
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
Recellularization via electroporation therapy found to be feasible and safe
